| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,851 |
12,309 |
$441K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
8,249 |
7,880 |
$215K |
| 59410 |
|
211 |
198 |
$206K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
2,259 |
617 |
$97K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,366 |
1,345 |
$87K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,210 |
1,150 |
$78K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,131 |
1,105 |
$71K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
784 |
772 |
$52K |
| 87428 |
|
1,743 |
1,695 |
$31K |
| 59515 |
|
29 |
24 |
$23K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,622 |
3,533 |
$18K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
318 |
315 |
$17K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
684 |
668 |
$16K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
263 |
239 |
$16K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,891 |
1,814 |
$15K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
192 |
187 |
$14K |
| 99222 |
Initial hospital care, per day, moderate complexity |
185 |
167 |
$14K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
95 |
95 |
$10K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
556 |
546 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,613 |
1,556 |
$6K |
| 92558 |
|
2,983 |
2,928 |
$5K |
| 99215 |
Prolong outpt/office vis |
104 |
102 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
2,794 |
2,648 |
$4K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
41 |
41 |
$3K |
| 3074F |
|
10,731 |
8,815 |
$2K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
53 |
52 |
$2K |
| 90474 |
|
209 |
207 |
$964.73 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
32 |
13 |
$909.69 |
| 85018 |
|
1,308 |
1,274 |
$857.04 |
| 90686 |
|
783 |
768 |
$732.89 |
| 83655 |
|
236 |
230 |
$723.45 |
| 90674 |
|
329 |
317 |
$576.36 |
| 81025 |
|
277 |
271 |
$562.22 |
| 96160 |
|
8,132 |
7,357 |
$507.13 |
| 90681 |
|
182 |
180 |
$450.00 |
| 90633 |
|
237 |
229 |
$400.01 |
| 3075F |
|
2,055 |
1,882 |
$400.00 |
| 99442 |
|
71 |
66 |
$317.29 |
| 81003 |
|
326 |
312 |
$284.07 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
25 |
$187.25 |
| 92250 |
|
14 |
13 |
$137.86 |
| 99441 |
|
27 |
25 |
$109.30 |
| 99173 |
|
4,086 |
3,402 |
$107.53 |
| 1036F |
|
8,722 |
7,709 |
$67.94 |
| 1126F |
|
6,290 |
4,775 |
$65.45 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
9,112 |
8,011 |
$38.70 |
| 36410 |
|
375 |
333 |
$33.43 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
277 |
274 |
$9.43 |
| 99000 |
|
5,269 |
4,677 |
$9.42 |
| 90670 |
|
367 |
362 |
$0.98 |
| 90715 |
|
26 |
26 |
$0.10 |
| 3077F |
|
1,841 |
1,329 |
$0.00 |
| 90710 |
|
191 |
188 |
$0.00 |
| 1159F |
|
9,419 |
8,639 |
$0.00 |
| 1160F |
|
9,978 |
9,207 |
$0.00 |
| 3078F |
|
9,841 |
7,111 |
$0.00 |
| 90734 |
|
142 |
142 |
$0.00 |
| 3046F |
|
335 |
316 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
25 |
25 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
8,618 |
7,068 |
$0.00 |
| 2028F |
|
25 |
25 |
$0.00 |
| 1158F |
|
49 |
49 |
$0.00 |
| 90671 |
|
184 |
174 |
$0.00 |
| 90700 |
|
15 |
15 |
$0.00 |
| 80061 |
Lipid panel |
105 |
99 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
157 |
128 |
$0.00 |
| 81002 |
|
47 |
47 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,564 |
4,047 |
$0.00 |
| 3079F |
|
4,860 |
4,170 |
$0.00 |
| 1125F |
|
3,127 |
2,916 |
$0.00 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
492 |
455 |
$0.00 |
| 3080F |
|
866 |
706 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
6,276 |
5,369 |
$0.00 |
| 36416 |
|
673 |
607 |
$0.00 |
| 1034F |
|
1,340 |
1,149 |
$0.00 |
| 3008F |
|
1,473 |
813 |
$0.00 |
| 1000F |
|
515 |
450 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
66 |
63 |
$0.00 |
| 90723 |
|
450 |
433 |
$0.00 |
| 90651 |
|
200 |
199 |
$0.00 |
| 90647 |
|
428 |
414 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
140 |
135 |
$0.00 |
| 90620 |
|
90 |
90 |
$0.00 |
| 1111F |
|
117 |
90 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28 |
28 |
$0.00 |
| 86361 |
|
13 |
13 |
$0.00 |
| 90696 |
|
25 |
24 |
$0.00 |
| 82962 |
|
89 |
88 |
$0.00 |
| 4000F |
|
199 |
177 |
$0.00 |
| 84436 |
|
12 |
12 |
$0.00 |
| 86592 |
|
13 |
13 |
$0.00 |
| G8418 |
Bmi is documented below normal parameters and a follow-up plan is documented |
60 |
55 |
$0.00 |
| 3061F |
|
13 |
13 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
85 |
82 |
$0.00 |
| 87536 |
|
14 |
14 |
$0.00 |